|
CA1339210C
(en)
|
1988-05-31 |
1997-08-05 |
John Lewicki |
Recombinant techniques for production of novel natriuretic and vasodilator peptides
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US6406697B1
(en)
|
1989-02-23 |
2002-06-18 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US6541610B1
(en)
|
1989-09-05 |
2003-04-01 |
Immunex Corporation |
Fusion proteins comprising tumor necrosis factor receptor
|
|
DE69108830T2
(de)
|
1990-04-20 |
1995-09-14 |
Hisayuki Matsuo |
Neue im schwein vorkommende physiologisch aktive peptide.
|
|
JP3026351B2
(ja)
|
1990-07-13 |
2000-03-27 |
壽之 松尾 |
ブタｃｎｐ遺伝子及び前駆体蛋白
|
|
JP2930380B2
(ja)
|
1990-07-13 |
1999-08-03 |
壽之 松尾 |
ブタ由来新規生理活性ペプチド（ｃｎｐ―５３）
|
|
JP2977158B2
(ja)
|
1990-09-07 |
1999-11-10 |
壽之 松尾 |
トリ由来新規生理活性ペプチド（ニワトリｃｎｐ）
|
|
JP2977159B2
(ja)
|
1990-09-07 |
1999-11-10 |
壽之 松尾 |
カエル由来新規生理活性ペプチド（カエルｃｎｐ）
|
|
JP3026352B2
(ja)
|
1990-09-11 |
2000-03-27 |
壽之 松尾 |
ラットＣＮＰｃＤＮＡ及び前駆体蛋白
|
|
JP3026354B2
(ja)
|
1990-09-27 |
2000-03-27 |
壽之 松尾 |
ヒトｃｎｐ遺伝子及び前駆体蛋白
|
|
JP2809533B2
(ja)
|
1991-01-31 |
1998-10-08 |
壽之 松尾 |
Ｃｎｐ類似体ペプチド
|
|
AU662155B2
(en)
|
1991-05-10 |
1995-08-24 |
Celtrix Pharmaceuticals, Inc. |
Targeted delivery of bone growth factors
|
|
AU6360394A
(en)
|
1993-03-03 |
1994-09-26 |
Mayo Foundation For Medical Education And Research |
Vasonatrin peptide and analogs thereof
|
|
WO1995005455A1
(en)
|
1993-08-13 |
1995-02-23 |
Rijksuniversiteit Te Groningen |
Pharmaceutical composition comprising phosphatase or a derivative thereof
|
|
US6525022B1
(en)
|
1993-11-12 |
2003-02-25 |
Genentech, Inc. |
Receptor specific atrial natriuretic peptides
|
|
ES2194895T3
(es)
|
1993-11-12 |
2003-12-01 |
Genentech Inc |
Peptidos natriureticas atriales especifico de un receptor.
|
|
US5846932A
(en)
|
1993-11-12 |
1998-12-08 |
Genentech, Inc. |
Receptor specific atrial natriuretic peptides
|
|
US5665704A
(en)
|
1993-11-12 |
1997-09-09 |
Genentech, Inc. |
Receptor specific atrial natriuretic peptides
|
|
JPH10500969A
(ja)
|
1994-06-02 |
1998-01-27 |
ベーリンガー マンハイム ゲゼルシャフト ミット ベシュレンクテル ハフツング |
カルジオジラチンフラグメントの調製方法、高度に精製されたカルジオジラチンフラグメント及びそれらの調製のための中間生成物類
|
|
JPH0870875A
(ja)
|
1994-09-05 |
1996-03-19 |
Tosoh Corp |
組換えアルカリフォスファタ−ゼ融合タンパク質
|
|
US5863782A
(en)
|
1995-04-19 |
1999-01-26 |
Women's And Children's Hospital |
Synthetic mammalian sulphamidase and genetic sequences encoding same
|
|
US6028055A
(en)
|
1996-10-22 |
2000-02-22 |
Genetech, Inc. |
Receptor selective BNP
|
|
EP0939770A1
(en)
|
1996-10-22 |
1999-09-08 |
Genentech, Inc. |
Receptor specific brain natriuretic peptide (bnp)
|
|
WO2000053755A2
(en)
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor
|
|
US6455495B1
(en)
|
1997-02-14 |
2002-09-24 |
The Salk Institute For Biological Studies |
Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
|
|
JP4394279B2
(ja)
|
1998-03-09 |
2010-01-06 |
ジーランド ファーマ アクティーゼルスカブ |
酵素加水分解に対する傾向が減少した薬理学的に活性なペプチド複合体
|
|
CA2245903A1
(en)
|
1998-09-28 |
2000-03-28 |
Mcgill University |
Use of pex in the treatment of metabolic bone diseases
|
|
CA2260376A1
(en)
|
1999-02-11 |
2000-08-11 |
Universite De Montreal |
New metalloproteases of the neprilysin family
|
|
CA2262056A1
(en)
|
1999-02-24 |
2000-08-24 |
Guy Boileau |
Composition, methods and reagents for the synthesis of a soluble form of human pex
|
|
JP2002542304A
(ja)
|
1999-04-28 |
2002-12-10 |
ベクトレイムド インコーポレイテッド |
酵素的に活性化された重合薬物接合体
|
|
US20040266673A1
(en)
|
2002-07-31 |
2004-12-30 |
Peter Bakis |
Long lasting natriuretic peptide derivatives
|
|
SI1105409T1
(sl)
|
1999-05-17 |
2006-06-30 |
Conjuchem Inc |
Zascita endogenih peptidov pred peptidazno ucinkovitostjo s konjugacijo na krvne komponente
|
|
JP2000327583A
(ja)
|
1999-05-17 |
2000-11-28 |
Medei Sci Puraningu:Kk |
骨指向性ホルモン誘導体
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
US6849714B1
(en)
|
1999-05-17 |
2005-02-01 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
DE19942230C2
(de)
|
1999-09-03 |
2003-09-25 |
Wolf-Georg Forssmann |
Verwendung natriuretischer Peptide als antibiotisch wirksame Subsanzen zur Behandlung von bakteriellen Infektionen
|
|
ATE360082T1
(de)
|
1999-11-16 |
2007-05-15 |
Genzyme Corp |
Vektoren und transgene mit regulatorischen elementen zur genverabreichung in leber
|
|
US6407211B1
(en)
|
1999-12-17 |
2002-06-18 |
Mayo Foundation For Medical Education And Research |
Chimeric natriuretic peptides
|
|
WO2001044257A1
(en)
|
1999-12-17 |
2001-06-21 |
Ariad Pharmaceuticals, Inc. |
Proton pump inhibitors
|
|
JP4237375B2
(ja)
|
2000-03-31 |
2009-03-11 |
アスビオファーマ株式会社 |
虚血性疾患の処置又は予防に用いる医薬組成物
|
|
IL152428A0
(en)
|
2000-04-26 |
2003-05-29 |
Univ Kingston |
Formulations and method of using nitric oxide mimetics against a malignant cell phenotype
|
|
EP1502604A1
(en)
|
2000-04-26 |
2005-02-02 |
Cellegy Pharmaceuticals, Inc |
Use of nitric oxide mimetics in cancer treatment
|
|
US7678391B2
(en)
|
2000-04-26 |
2010-03-16 |
Queen's University At Kingston |
Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
|
|
US20050142217A1
(en)
|
2000-04-26 |
2005-06-30 |
Adams Michael A. |
Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
|
|
US6830885B1
(en)
|
2000-08-18 |
2004-12-14 |
Phenogene Therapeutiques Inc. |
Nucleic acid molecule, method and kit for selecting a nucleic acid having a desired feature
|
|
DE60123635T2
(de)
|
2000-08-23 |
2007-08-16 |
Enobia Pharma Inc., Montreal |
Methode und zusammensetzung zur förderung von osteogenese
|
|
US6436386B1
(en)
|
2000-11-14 |
2002-08-20 |
Shearwater Corporation |
Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
|
|
UA93662C2
(uk)
|
2000-12-07 |
2011-03-10 |
Эли Лилли Энд Компани |
Гетерологічний пептидильований глюкагон-подібний білок та його застосування для виготовлення лікарського засобу для лікування пацієнтів, що страждають на ожиріння або інсулінонезалежний цукровий діабет
|
|
JP2002178279A
(ja)
|
2000-12-12 |
2002-06-25 |
Ulvac Japan Ltd |
基板搬送方法
|
|
WO2002068579A2
(en)
|
2001-01-10 |
2002-09-06 |
Pe Corporation (Ny) |
Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
|
|
JP2002246704A
(ja)
|
2001-02-16 |
2002-08-30 |
Philips Japan Ltd |
電子装置及び回路装置
|
|
IL142118A0
(en)
|
2001-03-20 |
2002-03-10 |
Prochon Biotech Ltd |
Method and composition for treatment of skeletal dysplasias
|
|
WO2002092020A2
(en)
|
2001-03-23 |
2002-11-21 |
The Burnham Institute |
Compositions and methods for modulating bone mineral deposition
|
|
US7888372B2
(en)
|
2001-03-23 |
2011-02-15 |
National Institutes Of Health (Nih) |
Compositions and methods for modulating bone mineral deposition
|
|
US6808905B2
(en)
|
2001-05-14 |
2004-10-26 |
Cell Genesys, Inc. |
Lentiviral vectors encoding clotting factors for gene therapy
|
|
AU2002367839A1
(en)
|
2001-07-16 |
2003-11-17 |
Hk Pharmaceuticals, Inc. |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
|
BRPI0203172B8
(pt)
|
2001-09-28 |
2021-05-25 |
Nakao Kazuwa |
composição farmacêutica para acondroplasia
|
|
US20050202442A1
(en)
|
2003-12-15 |
2005-09-15 |
Morris David W. |
Novel therapeutic targets in cancer
|
|
DE60239763D1
(de)
|
2001-12-20 |
2011-05-26 |
Enobia Pharma Inc |
Knochenpolypeptid-1
|
|
ES2425738T3
(es)
|
2001-12-21 |
2013-10-17 |
Human Genome Sciences, Inc. |
Proteínas de fusión de la albúmina
|
|
US20080194481A1
(en)
|
2001-12-21 |
2008-08-14 |
Human Genome Sciences, Inc. |
Albumin Fusion Proteins
|
|
US20030158132A1
(en)
|
2002-01-22 |
2003-08-21 |
Genvec, Inc. |
Method for enhancing bone density or formation
|
|
JP2005527510A
(ja)
|
2002-03-06 |
2005-09-15 |
セレジー ファーマシューティカルズ インコーポレーティッド |
癌の治療において一酸化窒素模倣体を使用するための製剤および方法
|
|
US20050113286A1
(en)
|
2002-03-18 |
2005-05-26 |
Schreiner George F. |
Methods for treating congestive heart failure
|
|
US20040077537A1
(en)
|
2002-03-18 |
2004-04-22 |
Schreiner George F. |
Method for treating congestive heart failure
|
|
IL149562A0
(en)
|
2002-05-09 |
2002-11-10 |
Prochon Ltd |
Fgf variants and methods for use thereof
|
|
CA2433479A1
(en)
|
2002-07-22 |
2004-01-22 |
F. Hoffmann-La Roche Ag |
Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof
|
|
EP1530588A2
(en)
|
2002-07-31 |
2005-05-18 |
Conjuchem, Inc. |
Long lasting natriuretic peptide derivatives
|
|
US20060110359A1
(en)
|
2002-09-06 |
2006-05-25 |
Juan Sanchez-Ramos |
Cellular delivery of natriuretic peptides
|
|
EP1562990B1
(en)
|
2002-11-18 |
2010-07-21 |
Syn X Pharma, Inc. |
Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
|
|
EP1569683B1
(en)
|
2002-11-26 |
2010-03-03 |
Biocon Limited |
Modified natriuretic compounds, conjugates, and uses thereof
|
|
US7648962B2
(en)
|
2002-11-26 |
2010-01-19 |
Biocon Limited |
Natriuretic compounds, conjugates, and uses thereof
|
|
WO2004050620A2
(en)
|
2002-12-03 |
2004-06-17 |
Enobia Pharma |
Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
|
|
US20060172929A1
(en)
|
2003-01-13 |
2006-08-03 |
Gudrun Rappold-Hoerbrand |
Use of natriuretic peptides for the treatment of stature disorders related to the shox gene
|
|
CA2516128A1
(en)
|
2003-02-14 |
2004-09-02 |
Sagres Discovery, Inc. |
Therapeutic targets in cancer
|
|
US7488713B2
(en)
|
2004-03-18 |
2009-02-10 |
University Of South Florida |
Cancer treatment using C-type natriuretic peptides
|
|
EP1616181B1
(en)
|
2003-04-17 |
2009-08-12 |
Vermillion, Inc. |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
|
CA2527878A1
(en)
|
2003-05-30 |
2005-01-27 |
Alexion Pharmaceuticals, Inc. |
Antibodies and fusion proteins that include engineered constant regions
|
|
DE602004030342D1
(de)
|
2003-06-17 |
2011-01-13 |
Otago Innovation Ltd |
Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden
|
|
DE602004029680D1
(de)
|
2003-06-20 |
2010-12-02 |
Mayo Foundation |
Isoformen von gehirn-natriuretischem peptid
|
|
WO2005052593A1
(en)
|
2003-10-29 |
2005-06-09 |
The University Of Leicester |
Detection
|
|
US7431915B2
(en)
|
2003-10-31 |
2008-10-07 |
The Regents Of The University Of California |
Peptides whose uptake by cells is controllable
|
|
JP2007531513A
(ja)
|
2003-11-13 |
2007-11-08 |
ハンミ ファーム．インダストリー カンパニー リミテッド |
薬物のキャリアとして有用なＩｇＧＦｃ断片およびその製造方法
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
WO2005070446A1
(en)
|
2004-01-15 |
2005-08-04 |
Scios Inc. |
Method for treating cardiac remodeling following myocardial injury
|
|
EP1730181A2
(en)
|
2004-01-27 |
2006-12-13 |
Compugen USA, Inc. |
Novel brain natriuretic peptide variants and methods of use thereof
|
|
US20080182299A1
(en)
|
2004-01-27 |
2008-07-31 |
Compugent Ltd. |
Novel brain natriuretic peptide variants and methods of use thereof
|
|
JP4825667B2
(ja)
|
2004-03-31 |
2011-11-30 |
一和 中尾 |
関節炎症治療剤又は予防剤
|
|
EP3620530A1
(en)
|
2004-03-31 |
2020-03-11 |
Kazuwa Nakao |
Composition for increasing body height
|
|
JP2005292718A
(ja)
|
2004-04-05 |
2005-10-20 |
Furukawa Electric Co Ltd:The |
光導波路、光導波路モジュールおよび光導波路の作成方法
|
|
HUE055861T2
(hu)
|
2004-04-21 |
2021-12-28 |
Alexion Pharma Inc |
Csontbejuttató konjugátumok és azok alkalmazási módszere fehérjék csonthoz kötéséhez
|
|
US20070142339A1
(en)
|
2004-05-10 |
2007-06-21 |
Novacea, Inc. |
Prevention of arterial restenosis with active vitamin d compounds
|
|
US7863238B2
(en)
|
2004-06-10 |
2011-01-04 |
Saint Louis University |
Proteins with an attached short peptide of acidic amino acids
|
|
US7972593B2
(en)
|
2004-06-10 |
2011-07-05 |
Saint Louis University |
Delivery of therapeutic agents to the bone
|
|
US20070081984A1
(en)
|
2005-10-11 |
2007-04-12 |
Shunji Tomatsu |
Compositions and methods for treating hypophosphatasia
|
|
US20070081986A1
(en)
|
2005-10-07 |
2007-04-12 |
Shunji Tomatsu |
Beta-glucuronidase with an attached short peptide of acidic amino acids
|
|
ATE496060T1
(de)
|
2004-07-15 |
2011-02-15 |
Univ Queensland |
Proteinartige verbindungen und anwendungen davon
|
|
WO2006039480A2
(en)
|
2004-09-29 |
2006-04-13 |
The Burnham Institute For Medical Research |
Tissue non-specific alkaline phosphate (tnap): a therapeutic target for arterial calcification
|
|
MX2007006524A
(es)
|
2004-12-01 |
2007-06-22 |
Genzyme Corp |
Metodos para el suministro dirigido de material genetico al higado.
|
|
EP2510942B1
(en)
|
2005-04-07 |
2015-09-02 |
Cardiorentis AG |
Use of natriuretic peptide for treating heart failure
|
|
WO2006116260A2
(en)
|
2005-04-26 |
2006-11-02 |
Medimmune, Inc. |
Modulation of antibody effector function by hinge domain engineering
|
|
US20070042957A1
(en)
|
2005-08-19 |
2007-02-22 |
Mayo Foundation For Medical Education And Research |
Type v phosphodiesterase inhibitors and natriuretic polypeptides
|
|
US7470668B2
(en)
|
2005-08-24 |
2008-12-30 |
Enobia Pharma Inc. |
Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof
|
|
EP1933863A4
(en)
|
2005-09-06 |
2010-06-09 |
Zelos Therapeutics Inc |
PARATHYROIDIAN HORMONE ANALOGS AND METHODS USING SAME
|
|
US7803901B2
(en)
|
2005-09-16 |
2010-09-28 |
Mayo Foundation For Medical Education And Research |
Polypeptides with natriuresis activity
|
|
WO2007041645A2
(en)
|
2005-10-03 |
2007-04-12 |
Scios Inc. |
Oxidized human bnp
|
|
RU2316334C2
(ru)
|
2005-12-19 |
2008-02-10 |
Медитек Индастриз ЛЛС |
Способ активации утраченных двигательных функций, а также определения эффективности их восстановления при повреждении центральной нервной системы
|
|
US7625564B2
(en)
|
2006-01-27 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
|
|
CA2638912A1
(en)
|
2006-02-20 |
2007-08-30 |
Phylogica Limited |
Method of constructing and screening libraries of peptide structures
|
|
US8784833B2
(en)
|
2006-06-27 |
2014-07-22 |
Saint Louis University |
Prenatal enzyme replacement therapy for hypophosphatasia
|
|
WO2008053362A2
(en)
|
2006-06-30 |
2008-05-08 |
Interface Biologics, Inc. |
Bioresponsive polymers
|
|
US7825092B2
(en)
|
2006-08-08 |
2010-11-02 |
University Of South Florida |
Dendroaspis natriuretic peptide for treatment of cancer
|
|
EP2054433B1
(en)
|
2006-08-08 |
2017-12-13 |
Mayo Foundation For Medical Education And Research |
Diuretic and natriuretic polypeptides
|
|
DK2615108T3
(en)
|
2006-09-08 |
2017-01-30 |
Ambrx Inc |
Modified human plasma polypeptide or fc scaffolds and their applications
|
|
BRPI0716228A2
(pt)
|
2006-09-08 |
2013-10-15 |
Mayo Foundation |
Polipeptídeos aquaréticos e natriuréticos carecendo de atividade vasodilatadora
|
|
PE20081140A1
(es)
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
WO2008058016A2
(en)
|
2006-11-02 |
2008-05-15 |
University Of Virginia Patent Foundation |
Ethoid-containing compounds, methods for preparing ethoid-containing compounds, and methods for use
|
|
CN101668421B
(zh)
|
2006-11-16 |
2014-05-21 |
凯制药公司 |
用于治疗甲状旁腺功能亢进和高钙血症的聚阳离子钙调节肽
|
|
US20080181903A1
(en)
|
2006-12-21 |
2008-07-31 |
Pdl Biopharma, Inc. |
Conjugate of natriuretic peptide and antibody constant region
|
|
WO2008109903A1
(en)
|
2007-03-12 |
2008-09-18 |
Biomedica Medizinprodukte Gmbh & Co Kg |
Diagnosis of septic complications
|
|
EP1985697A1
(en)
|
2007-04-27 |
2008-10-29 |
AM-Pharma B.V. |
Modified phosphatases
|
|
KR20080098216A
(ko)
|
2007-05-04 |
2008-11-07 |
한미약품 주식회사 |
캐리어 물질을 이용한 나트륨 배설 펩타이드 약물 결합체
|
|
PL2158319T4
(pl)
|
2007-05-11 |
2016-04-29 |
Alexion Pharma Inc |
Fosfataza alkaliczna kierowana do kości, zestawy i zastosowanie
|
|
KR20100021601A
(ko)
|
2007-05-14 |
2010-02-25 |
바이오겐 아이덱 엠에이 인코포레이티드 |
단일-쇄 Ｆｃ(ＳｃＦｃ) 부분, 이를 포함하는 결합 폴리펩타이드, 및 이에 관련된 방법
|
|
US20100310561A1
(en)
|
2007-06-06 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
Natriuretic fusion proteins
|
|
WO2008154543A2
(en)
|
2007-06-11 |
2008-12-18 |
Abbott Biotechnology Ltd. |
Methods for treating juvenile idiopathic arthritis
|
|
WO2009006520A1
(en)
|
2007-07-03 |
2009-01-08 |
Medimmune, Llc |
Hinge domain engineering
|
|
AP2009005091A0
(en)
|
2007-07-06 |
2009-12-31 |
Theratechnologies Inc |
Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (ALPHA-MSH) and atrial natriuretic protein (ANP) and uses in hypertension andacute kidney injury
|
|
AU2008279379B2
(en)
|
2007-07-20 |
2016-03-24 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides
|
|
US20090053192A1
(en)
|
2007-08-10 |
2009-02-26 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
CN103298935A
(zh)
|
2007-08-15 |
2013-09-11 |
阿穆尼克斯公司 |
用于改善生物活性多肽性能的组合物和方法
|
|
ES2575397T3
(es)
|
2007-09-11 |
2016-06-28 |
Cardiopep Pharma Gmbh |
Uso de péptidos natriuréticos para el tratamiento de síndromes de angioedema
|
|
CA2699073A1
(en)
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
CA2699169A1
(en)
|
2007-09-11 |
2009-04-16 |
Mondobiotech Laboratories Ag |
Therapeutic uses of intermedin 47 and 53 peptides
|
|
EP2187953A2
(en)
|
2007-09-11 |
2010-05-26 |
Mondobiotech Laboratories AG |
Use of a peptide as a therapeutic agent
|
|
CA2699100A1
(en)
|
2007-09-11 |
2009-04-02 |
Dorian Bevec |
Use of a peptide as a therapeutic agent
|
|
AU2008297893A1
(en)
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of a deslorelin and mastoparan as a therapeutic agent
|
|
WO2009036448A2
(en)
|
2007-09-15 |
2009-03-19 |
Mayo Foundation For Medical Education And Research |
Natriuretic peptide receptor-c agonists
|
|
AU2008326327A1
(en)
|
2007-11-21 |
2009-05-28 |
Biomarin Pharmaceutical Inc. |
Variants of C-type natriuretic peptide
|
|
WO2009086126A2
(en)
|
2007-12-21 |
2009-07-09 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides
|
|
EP2080812A1
(en)
|
2008-01-18 |
2009-07-22 |
Transmedi SA |
Compositions and methods of detecting post-stop peptides
|
|
HRP20160303T1
(hr)
|
2008-05-23 |
2016-04-22 |
Daiichi Sankyo Company, Limited |
Peptid koji je sposoban produljiti vrijeme polu-života pogodnih peptida u plazmi
|
|
CA2727085A1
(en)
|
2008-06-06 |
2009-12-10 |
Mayo Foundation For Medical Education And Research |
Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling
|
|
WO2009156481A1
(en)
|
2008-06-25 |
2009-12-30 |
Ascendis Pharma As |
Pegylated bnp
|
|
KR101871510B1
(ko)
|
2008-06-26 |
2018-06-26 |
악셀레론 파마 인코포레이티드 |
액티빈-ａｃｔｒｉｉａ 길항물질을 투약하는 방법 및 치료된 환자의 모니터링
|
|
EP2307447B1
(en)
|
2008-07-02 |
2016-03-09 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides with unique pharmacologic profiles
|
|
EP2300501B1
(en)
|
2008-07-23 |
2014-08-20 |
Hanmi Science Co., Ltd. |
A polypeptide complex comprising non-peptidyl polymer having three functional ends
|
|
US20100093678A1
(en)
|
2008-10-10 |
2010-04-15 |
The University Of Georgia Research Foundation, Inc |
Compositions and methods of the treatment of obesity and osteoporosis
|
|
US8642550B2
(en)
|
2008-10-24 |
2014-02-04 |
Mayo Foundation For Medical Education And Research |
Chimeric natriuretic peptides without hypotensive inducing capability
|
|
WO2010078325A2
(en)
|
2008-12-29 |
2010-07-08 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides for reducing or preventing restenosis
|
|
AR075029A1
(es)
|
2009-01-19 |
2011-03-02 |
Hanmi Pharm Ind Co Ltd |
Metodo para producir una proteina o un peptido fisiologicamente activo usando un fragmento de inmunoglobulina
|
|
JP2012521784A
(ja)
|
2009-03-30 |
2012-09-20 |
ベーリンガー・インゲルハイム・インテルナツィオナール・ゲーエムバーハー |
イヌＦｃ部分を含む融合タンパク質
|
|
US20120053123A1
(en)
|
2009-05-05 |
2012-03-01 |
Mayo Foundation For Medical Education And Research |
Natriuretic polypeptides having mutations within their disulfide rings
|
|
PE20120792A1
(es)
|
2009-05-20 |
2012-07-27 |
Biomarin Pharm Inc |
Variantes de peptidos natriureticos de tipo c
|
|
BR112012027765A2
(pt)
|
2010-04-30 |
2019-09-24 |
Enobia Pharma Inc |
métodos, composições e kits para tratamento de distúrbios de mineralização da matriz.
|
|
US9266939B2
(en)
|
2010-12-27 |
2016-02-23 |
Alexion Pharmaceuticals, Inc. |
Compositions comprising natriuretic peptides and methods of use thereof
|
|
SG11201401605QA
(en)
|
2011-10-19 |
2014-09-26 |
Alexion Pharma Holding |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
AU2012335009B2
(en)
|
2011-11-10 |
2017-08-31 |
Kai Pharmaceuticals, Inc. |
Calcimimetics and methods for their use
|
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
JP2015526423A
(ja)
|
2012-07-25 |
2015-09-10 |
サイオクサス セラピューティクス リミテッド |
カヘキシア及びサルコペニアを治療するためのｓ−ピンドロールの使用
|
|
PT3461891T
(pt)
|
2014-01-24 |
2020-07-30 |
Am Pharma Bv |
Processamento a jusante de uma fosfatase alcalina
|
|
HRP20251099T1
(hr)
|
2014-06-09 |
2025-11-07 |
Ultragenyx Pharmaceutical Inc. |
Učinkovita i djelotvorna kontrola serumskog fosfata za optimalno stvaranje kostiju
|
|
WO2016007873A1
(en)
*
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
|
CA2967851C
(en)
*
|
2014-12-05 |
2024-02-27 |
Alexion Pharmaceuticals, Inc. |
Treating seizure with recombinant alkaline phosphatase
|
|
AU2016211447B2
(en)
|
2015-01-28 |
2021-09-23 |
Alexion Pharmaceuticals, Inc. |
Methods of treating a subject with an alkaline phosphatase deficiency
|
|
EP3337894A1
(en)
|
2015-08-17 |
2018-06-27 |
Alexion Pharmaceuticals, Inc. |
Manufacturing of alkaline phosphatases
|
|
JP6868617B2
(ja)
|
2015-09-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
|
|
US11400140B2
(en)
|
2015-10-30 |
2022-08-02 |
Alexion Pharmaceuticals, Inc. |
Methods for treating craniosynostosis in a patient
|
|
US11065306B2
(en)
|
2016-03-08 |
2021-07-20 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
|
WO2017173395A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
|
KR20220162816A
(ko)
|
2016-04-01 |
2022-12-08 |
알렉시온 파마슈티칼스, 인코포레이티드 |
알칼리성 포스파타아제로 근육 약화의 치료
|
|
WO2017171871A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
|
US10988744B2
(en)
|
2016-06-06 |
2021-04-27 |
Alexion Pharmaceuticals, Inc. |
Method of producing alkaline phosphatase
|
|
EP3474886B1
(en)
|
2016-06-27 |
2021-08-04 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children and adolescents
|
|
WO2018035420A1
(en)
|
2016-08-18 |
2018-02-22 |
Alexion Pharmaceuticals, Inc. |
Methods for treating tracheobronchomalacia
|